Masterclass series in peripheral arterial disease

Fowkes FGR , Lowe GDO , Housley E et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993; 342: 84-86.

Tait RC , Walker ID , Perry DJ et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994; 87: 106-112.

Tait RC , Walker ID , Reitsma PH et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995; 73: 87-93.

Dykes AC , Walker ID , McMahon AD , Islam SIAM , Tait RC. A study of protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 2001; 113: 636-641.

Bertina RM , Koeleman BPC , Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.

Rees DC , Cox M , Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-1134.

Camerlingo M , Finazzi G , Casto L , Laffranchi C , Barbui T , Mamoli A. Inherited protein C deficiency and nonhemorrhagic arterial stroke in young adults. Neurology 1991; 41: 1371-1373.

Grewal RP , Goldberg MA. Stroke in protein C deficiency. Am J Med 1990; 89: 538-539.

Kohler J , Kasper J , Witt I , von Reutern G-M. Ischemic stroke due to protein C deficiency. Stroke 1990; 21: 1077-1080.

Munts AG , van Genderen PJJ , Dippel DWJ , van Kooten F , Koudstaal PJ. Coagulation disorders in young adults with acute cerebral ischaemia. JNeurol 1998; 245: 21-25.

Doggen CJM , Cats VM , Bertina RM , Rosendaal FR. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210 A. Circulation 1998; 97: 1037-1041.

Donaldson MC , Weinberg DS , Belkin M , Whittemore AD , Mannick JA. Screening for hypercoagulable states in vascular surgical practice: a preliminary study. J Vasc Surg 1990; 11: 825-831.

Ray SA , Rowley MR , Loh A et al. Hypercoagulable states in patients with leg ischaemia. Br J Surg 1994; 81: 811-814.

Valentine RJ , Kaplan HS , Green R et al. Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis. J Vasc Surg 1996; 23: 53-63.

Eldrup-Jorgensen J , Flanigan DP , Brace L et al. Hypercoagulable states and lower limb ischemia in young adults. J Vasc Surg 1989; 9: 334-341.

Allaart CF , Aronson DC , Ruys T et al. Hereditary protein S deficiency in young adults with arterial occlusive disease. Thromb Haemost 1990; 64: 206-210.

Sampram ESK , Lindblad B , Dahlback B. Activated protein C resistance in patients with peripheral vascular disease. J Vasc Surg 1998; 28: 624-629.

Foley PWX , Irvine CD , Standen GR et al. Activated protein C resistance, factor V Leiden and peripheral and vascular disease. Cardiovasc Surg 1997; 5: 157-160.

Arruda VR , Annichino-Bizzacchi JM , Goncalves MS , Costa FF. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997; 78: 1430-1433.

Ray SA , Rowley MR , Bevan DH , Taylor RS , Dormandy JA. Hyper-coagulable abnormalities and postoperative failure of arterial reconstruction. Eur J Vasc Endovasc Surg 1997; 13: 363-370.

Arfvidsson B , Lundgren F , Drott C , Schersten T , Lundholm K. Influence of coumarin treatment of patency and limb salvage after peripheral arterial reconstructive surgery. Am J Surg 1990; 159: 556-560.

Kretschmer G , Herbst F , Prager M et al. A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis. Arch Surg 1992; 127: 1112-1115.

Tangelder MJD , Algra A , Lawson JA et al. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial. Lancet 2000; 355: 346-351.